Angiotensin II Acetate and Kovaltry recombinant

• Generic Name: angiotensin II
• Dosage Forms: n.a.
• Other Brand Names: Giapreza

Used to increase BP in patients with septic or other distributive shock.

Substantially and rapidly increases mean arterial pressure (MAP) in patients who remain hypotensive despite fluid and vasopressor therapy.

May have a catecholamine-sparing effect, but effects on mortality not established.

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Kovaltry is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Kovaltry is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Kovaltry is not for use in people with von Willebrand disease.

Recombinant Kovaltry may also be used for purposes not listed in this medication guide.